Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schönlein purpura nephritis

Abstract

We aimed to investigate the differences in renal histopathological changes and laboratory parameters between adult and pediatric patients with Henoch-Schönlein purpura nephritis (HSPN), and to analyze the correlation between laboratory parameters and renal histopathological grading. A total of 139 patients diagnosed with HSPN between September 2010 and December 2014 at the First Hospital of Jilin University, China, were retrospectively reviewed. The clinical and pathological characteristics were examined and compared between the adult and the pediatric patients. A majority of adult (75.0%) and pediatric (66.2%) patients were categorized as pathological grade III HSPN. Adults having crescent lesions, interstitial fibrosis and renal artery involvement significantly outnumbered child counterparts (all P<0.05). Pathological grading showed a positive correlation with 24-h urine protein (r=0.307, P=0.009), microalbuminuria (r=0.266, P=0.000) and serum globulin (r=0.307, P=0.014), and a negative correlation with serum albumin (r=0.249, P=0.037) in pediatric patients with HSPN. Among adult patients with HSPN, histopathological grading showed a positive correlation with 24-h urine protein (r=0.294, P=0.015), microalbuminuria (r=0.352, P=0.006), α1-microglobulin (r=0.311, P=0.019) and immunoglobulin G (r=0.301, P=0.023) in urine, and serum creatinine (r=0.292, P=0.018). Further, a negative correlation between serum albumin and pathological grading was also observed (r=0.291, P=0.018). In conclusion, the severity of renal pathological lesions in HSPN patients is well reflected by the levels of proteinuria. Adult patients have more severe renal histopathological changes than pediatric patients.

Keywords

Henoch-SchÖnlein purpura nephritis / child / adult / renal biopsy

References

[1] FTS. Epidemiology of Henoch-Schönlein purpura. Cleve Clin J Med, 2002, 69: 187-189

[2] KangY, ParkJS, HaYJ, et al. . Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci, 2014, 29(2): 198-203 PMID: 24550645 PMCID: 3923997

[3] MirS, YavascanO, MutlubasF, et al. . Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol, 2007, 22(1): 64-70 PMID: 17024391

[4] NarchiH. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child, 2005, 90(9): 916-920 PMID: 15871983 PMCID: 1720564

[5] JauholaO, RonkainenJ, KoskimiesO, et al. . Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child, 2010, 95(11): 877-882 PMID: 20852275

[6] WakakiH, IshikuraK, HatayaH, et al. . Henoch-Schonlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol, 2011, 26(6): 921-925 PMID: 21373776

[7] Garcia-PorruaC, CalvinoMC, LlorcaJ, et al. . Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum, 2002, 32(3): 149-156 PMID: 12528079

[8] MillsJ M, BlochDA, CalabreseLH, et al. . The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum, 1990, 33: 1114-1121 PMID: 2202310

[9] HaasM. JennetteJ O, SchwartzMM, SilvaFG. IgA nephropathy and Henoch–Schönlein purpura nephritis. Heptinstall’s pathology of the kidney, 2006, Philadelphia, Lippincott Williams & Wilkins, 423-486

[10] PohlM. Henoch-Schonlein purpura nephritis. Pediatr Nephrol, 2015, 30(2): 245-252 PMID: 24733586

[11] FretzayasA, SiontiI, MoustakiM, et al. . Henoch-SchÖ nlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol, 2008, 14(6): 324-331 PMID: 18703982

[12] ChoongCK, BeasleySW. Intra-abdominal manifestations of Henoch-SchÖnlein purpura. J Paediatr Child Health, 1998, 34(5): 405-409 PMID: 9767498

[13] PilleboutE, ThervetE, HillG, et al. . Henoch-SchÖnlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol, 2002, 13(5): 1271-1278 PMID: 11961015

[14] ZhangJN, LvYQ, XuFF, et al. . Analysis of clinical manifestation, pathological features and prognosis in adult and child patients with HSPN. Zhong Guo Zhong Xi Yi Jie He Za Zhi (Chinese), 2009, 10(1): 33-35

[15] KawasakiY S-S, SchaeferF. Comprehensive Pediatric Nephrology, 2008, Philadelphia, Mosby Elsevier, 343-351

[16] DavinJ T, WeeningJJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?. Kidney Int, 2001, 59(3): 823-834 PMID: 11231337

[17] BogdanovicR. Henoch-Schonlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr, 2009, 98(12): 1882-1889 PMID: 19650836

[18] Edstrom HallingS, SoderbergMP, BergUB. Predictors of outcome in Henoch-SchÖnlein nephritis. Pediatr Nephrol, 2010, 25(6): 1101-1108 PMID: 20174831

[19] DavinJC. Henoch-SchÖnlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol, 2011, 6(3): 679-689 PMID: 21393485

[20] GoldsteinAR, WhiteRH, AkuseR, et al. . Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet, 1992, 339(8788): 280-282 PMID: 1346291

[21] StewartM, SavageJM, BellB, et al. . Long term renal prognosis of Henoch-SchÖnlein purpura in an unselected childhood population. Eur J Pediatr, 1988, 147(2): 113-115 PMID: 3366130